Joshua Brumm is Chief Executive Officer & Director of Crescent Biopharma, Inc. (CBIO). The company reported total compensation of $13,116,834 for fiscal year 2025.
| Salary | $554,167 |
|---|---|
| Bonus | — |
| Stock awards | $2,381,440 |
| Option awards | $9,635,227 |
| Non-equity incentive plan | $546,000 |
| Pension and non-qualified deferred compensation | — |
| All other compensation | — |
| Total | $13,116,834 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Crescent Biopharma, Inc. filed April 21, 2026, accession 0001628280-26-026282.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Joshua Brumm this page | Chief Executive Officer & Director | $13,116,834 |
| Jonathan McNeill | Chief Operating Officer & President | $6,604,328 |
| Ellie Im | Chief Medical Officer | $3,662,495 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Crescent Biopharma, Inc. compensation brief.
Joshua Brumm's compensation sits inside Crescent Biopharma, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.